BLACKSTONE INC (BX)

US09260D1072 - Common Stock

170.84  +1.93 (+1.14%)

After market: 170.84 0 (0%)

Fundamental Rating

5

Overall BX gets a fundamental rating of 5 out of 10. We evaluated BX against 220 industry peers in the Capital Markets industry. BX has an average financial health and profitability rating. While showing a medium growth rate, BX is valued expensive at the moment.



6

1. Profitability

1.1 Basic Checks

In the past year BX was profitable.
In the past year BX had a positive cash flow from operations.
BX had positive earnings in each of the past 5 years.
In the past 5 years BX always reported a positive cash flow from operatings.

1.2 Ratios

BX has a better Return On Assets (5.22%) than 70.97% of its industry peers.
Looking at the Return On Equity, with a value of 31.74%, BX belongs to the top of the industry, outperforming 96.77% of the companies in the same industry.
BX has a better Return On Invested Capital (15.68%) than 92.17% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for BX is significantly above the industry average of 7.00%.
Industry RankSector Rank
ROA 5.22%
ROE 31.74%
ROIC 15.68%
ROA(3y)7.26%
ROA(5y)6.41%
ROE(3y)35.13%
ROE(5y)30.07%
ROIC(3y)19.39%
ROIC(5y)16.24%

1.3 Margins

Looking at the Profit Margin, with a value of 19.46%, BX is in line with its industry, outperforming 56.22% of the companies in the same industry.
BX's Profit Margin has declined in the last couple of years.
With an excellent Operating Margin value of 49.06%, BX belongs to the best of the industry, outperforming 83.41% of the companies in the same industry.
BX's Operating Margin has declined in the last couple of years.
Industry RankSector Rank
OM 49.06%
PM (TTM) 19.46%
GM N/A
OM growth 3Y-1.78%
OM growth 5Y-3.22%
PM growth 3Y0.41%
PM growth 5Y-5.14%
GM growth 3YN/A
GM growth 5YN/A

4

2. Health

2.1 Basic Checks

BX has more shares outstanding than it did 1 year ago.
BX has more shares outstanding than it did 5 years ago.
BX has a better debt/assets ratio than last year.

2.2 Solvency

BX has an Altman-Z score of 4.11. This indicates that BX is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 4.11, BX belongs to the top of the industry, outperforming 83.41% of the companies in the same industry.
BX has a debt to FCF ratio of 2.60. This is a good value and a sign of high solvency as BX would need 2.60 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.60, BX belongs to the top of the industry, outperforming 82.95% of the companies in the same industry.
BX has a Debt/Equity ratio of 1.53. This is a high value indicating a heavy dependency on external financing.
BX's Debt to Equity ratio of 1.53 is on the low side compared to the rest of the industry. BX is outperformed by 70.97% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.53
Debt/FCF 2.6
Altman-Z 4.11
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 0.67 indicates that BX may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.67, BX is doing worse than 67.74% of the companies in the same industry.
BX has a Quick Ratio of 0.67. This is a bad value and indicates that BX is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.67, BX is not doing good in the industry: 67.28% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.67
Quick Ratio 0.67

6

3. Growth

3.1 Past

BX shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 3.84%.
Measured over the past years, BX shows a quite strong growth in Earnings Per Share. The EPS has been growing by 10.85% on average per year.
Looking at the last year, BX shows a very strong growth in Revenue. The Revenue has grown by 35.42%.
The Revenue has been growing slightly by 3.26% on average over the past years.
EPS 1Y (TTM)3.84%
EPS 3Y14.23%
EPS 5Y10.85%
EPS Q2Q%7.45%
Revenue 1Y (TTM)35.42%
Revenue growth 3Y9.55%
Revenue growth 5Y3.26%
Sales Q2Q%4.83%

3.2 Future

BX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.57% yearly.
BX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 17.18% yearly.
EPS Next Y14.34%
EPS Next 2Y23.46%
EPS Next 3Y22.29%
EPS Next 5Y14.57%
Revenue Next Year15.95%
Revenue Next 2Y22.69%
Revenue Next 3Y20%
Revenue Next 5Y17.18%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 42.08, BX can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of BX indicates a slightly more expensive valuation: BX is more expensive than 79.26% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 27.73. BX is valued rather expensively when compared to this.
Based on the Price/Forward Earnings ratio of 28.38, the valuation of BX can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BX indicates a slightly more expensive valuation: BX is more expensive than 72.81% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.83, BX is valued a bit more expensive.
Industry RankSector Rank
PE 42.08
Fwd PE 28.38

4.2 Price Multiples

BX's Enterprise Value to EBITDA is on the same level as the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of BX indicates a slightly more expensive valuation: BX is more expensive than 60.37% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 50.11
EV/EBITDA 38.17

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of BX may justify a higher PE ratio.
BX's earnings are expected to grow with 22.29% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.94
PEG (5Y)3.88
EPS Next 2Y23.46%
EPS Next 3Y22.29%

3

5. Dividend

5.1 Amount

BX has a Yearly Dividend Yield of 2.04%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 9.45, BX is paying slightly less dividend.
Compared to an average S&P500 Dividend Yield of 2.34, BX has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.04%

5.2 History

The dividend of BX has a limited annual growth rate of 5.34%.
BX has been paying a dividend for at least 10 years, so it has a reliable track record.
BX has decreased its dividend recently.
Dividend Growth(5Y)5.34%
Div Incr Years1
Div Non Decr Years1

5.3 Sustainability

196.69% of the earnings are spent on dividend by BX. This is not a sustainable payout ratio.
The dividend of BX is growing, but earnings are growing more, so the dividend growth is sustainable.
DP196.69%
EPS Next 2Y23.46%
EPS Next 3Y22.29%

BLACKSTONE INC

NYSE:BX (12/20/2024, 9:51:47 PM)

After market: 170.84 0 (0%)

170.84

+1.93 (+1.14%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)10-17 2024-10-17/bmo
Earnings (Next)01-23 2025-01-23/amc
Inst Owners69.97%
Inst Owner Change1.22%
Ins Owners0.77%
Ins Owner Change-2.94%
Market Cap207.21B
Analysts72.5
Price Target173.99 (1.84%)
Short Float %2.3%
Short Ratio5.09
Dividend
Industry RankSector Rank
Dividend Yield 2.04%
Dividend Growth(5Y)5.34%
DP196.69%
Div Incr Years1
Div Non Decr Years1
Ex-Date10-28 2024-10-28 (0.86)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.58%
Min EPS beat(2)-5.35%
Max EPS beat(2)6.51%
EPS beat(4)2
Avg EPS beat(4)3.32%
Min EPS beat(4)-5.35%
Max EPS beat(4)13.42%
EPS beat(8)3
Avg EPS beat(8)1.23%
EPS beat(12)7
Avg EPS beat(12)6.41%
EPS beat(16)11
Avg EPS beat(16)10.17%
Revenue beat(2)0
Avg Revenue beat(2)-4.28%
Min Revenue beat(2)-6.69%
Max Revenue beat(2)-1.86%
Revenue beat(4)0
Avg Revenue beat(4)-3.31%
Min Revenue beat(4)-6.69%
Max Revenue beat(4)-0.38%
Revenue beat(8)0
Avg Revenue beat(8)-14.6%
Revenue beat(12)2
Avg Revenue beat(12)-5.64%
Revenue beat(16)6
Avg Revenue beat(16)34.07%
PT rev (1m)4.55%
PT rev (3m)25.37%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-9.58%
EPS NY rev (1m)0.27%
EPS NY rev (3m)-3.4%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.77%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.39%
Valuation
Industry RankSector Rank
PE 42.08
Fwd PE 28.38
P/S 18.12
P/FCF 50.11
P/OCF 49.15
P/B 29.57
P/tB 41.92
EV/EBITDA 38.17
EPS(TTM)4.06
EY2.38%
EPS(NY)6.02
Fwd EY3.52%
FCF(TTM)3.41
FCFY2%
OCF(TTM)3.48
OCFY2.03%
SpS9.43
BVpS5.78
TBVpS4.08
PEG (NY)2.94
PEG (5Y)3.88
Profitability
Industry RankSector Rank
ROA 5.22%
ROE 31.74%
ROCE 18.56%
ROIC 15.68%
ROICexc 17.12%
ROICexgc 18.62%
OM 49.06%
PM (TTM) 19.46%
GM N/A
FCFM 36.17%
ROA(3y)7.26%
ROA(5y)6.41%
ROE(3y)35.13%
ROE(5y)30.07%
ROIC(3y)19.39%
ROIC(5y)16.24%
ROICexc(3y)21.38%
ROICexc(5y)17.93%
ROICexgc(3y)23.38%
ROICexgc(5y)19.79%
ROCE(3y)23.01%
ROCE(5y)19.29%
ROICexcg growth 3Y-5.95%
ROICexcg growth 5Y-4.36%
ROICexc growth 3Y-4.42%
ROICexc growth 5Y-3.85%
OM growth 3Y-1.78%
OM growth 5Y-3.22%
PM growth 3Y0.41%
PM growth 5Y-5.14%
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.27
Health
Industry RankSector Rank
Debt/Equity 1.53
Debt/FCF 2.6
Debt/EBITDA 1.9
Cap/Depr 225.1%
Cap/Sales 0.71%
Interest Coverage 14.85
Cash Conversion 74.69%
Profit Quality 185.9%
Current Ratio 0.67
Quick Ratio 0.67
Altman-Z 4.11
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)332.12%
Cap/Depr(5y)247.68%
Cap/Sales(3y)1.95%
Cap/Sales(5y)1.7%
Profit Quality(3y)230.51%
Profit Quality(5y)191.78%
High Growth Momentum
Growth
EPS 1Y (TTM)3.84%
EPS 3Y14.23%
EPS 5Y10.85%
EPS Q2Q%7.45%
EPS Next Y14.34%
EPS Next 2Y23.46%
EPS Next 3Y22.29%
EPS Next 5Y14.57%
Revenue 1Y (TTM)35.42%
Revenue growth 3Y9.55%
Revenue growth 5Y3.26%
Sales Q2Q%4.83%
Revenue Next Year15.95%
Revenue Next 2Y22.69%
Revenue Next 3Y20%
Revenue Next 5Y17.18%
EBIT growth 1Y49.35%
EBIT growth 3Y7.6%
EBIT growth 5Y-0.07%
EBIT Next Year31.82%
EBIT Next 3Y30.38%
EBIT Next 5Y15.68%
FCF growth 1Y-10.12%
FCF growth 3Y28.08%
FCF growth 5Y168.82%
OCF growth 1Y-12.3%
OCF growth 3Y27.97%
OCF growth 5Y145.28%